Lupin and Novartis Healthcare Pvt Ltd have entered into a co-marketing agreement to promote Novartis’s Indacaterol/Glycopyrronium 110mcg/50mcg inhaler, a treatment for chronic obstructive pulmonary disease (COPD) under the brand name of Loftair.
Sun Pharma Laboratories, the wholly a subsidiary of Sun Pharmaceutical Industries, and Punjab-based Psyco Remedies have finally settled a trademark dispute over Syzopin, an anti psychotic drug- produced and marketed by the latter amicably.
Lupin and Novartis Healthcare Pvt Ltd have entered into a co-marketing agreement to promote Novartis’s Indacaterol/Glycopyrronium 110mcg/50mcg inhaler, a treatment for chronic obstructive pulmonary disease (COPD) under the brand name of Loftair.
On 28th March, Biocon Ltd said it has got a regulatory approval to launch the biosimilar version of insulin glargine in Japan. The 14.2% rise in Biocon’s share price since then partially stems from this approval and also due to re-rating of the stock by Morgan Stanley. A biosimilar is a drug that is similar to the original biological product.
Chennai-based Orchid Pharma Ltd has informed the Bombay Stock Exchange that the company received the establishment inspection report (EIR) from the US FDA based on the successful inspection closure for the API manufacturing facility located at Alathur, Kancheepuram District, Tamil Nadu. The facility was inspected by the US health regulator in August 2015.
Lyka Labs Ltd has announced that Lyka Healthcare Limited, a wholly owned subsidiary of Lyka Labs Limited, has launched two domestic marketing divisions in the name of ENSPAN and CERABELLE.
As per its expansion plan earmarked for financial year 2016-17, Dr Batra’s Healthcare is planning to add around 20 new homeopathy clinics across India and abroad.
Agriculture minister Radha Mohan Singh has said that the government will not allow companies such as Monsanto to exploit farmers and it will continue to regulate the prices of seeds and pharmaceuticals. “Monsanto is a good company.
Lupin and Novartis Healthcare Pvt Ltd have entered into a co-marketing agreement to promote Novartis’s Indacaterol/Glycopyrronium 110mcg/50mcg inhaler, a treatment for chronic obstructive pulmonary disease (COPD) under the brand name of Loftair.
On 28th March, Biocon Ltd said it has got a regulatory approval to launch the biosimilar version of insulin glargine in Japan. The 14.2% rise in Biocon’s share price since then partially stems from this approval and also due to re-rating of the stock by Morgan Stanley. A biosimilar is a drug that is similar to the original biological product.
Chennai-based Orchid Pharma Ltd has informed the Bombay Stock Exchange that the company received the establishment inspection report (EIR) from the US FDA based on the successful inspection closure for the API manufacturing facility located at Alathur, Kancheepuram District, Tamil Nadu. The facility was inspected by the US health regulator in August 2015.
Lyka Labs Ltd has announced that Lyka Healthcare Limited, a wholly owned subsidiary of Lyka Labs Limited, has launched two domestic marketing divisions in the name of ENSPAN and CERABELLE.
As per its expansion plan earmarked for financial year 2016-17, Dr Batra’s Healthcare is planning to add around 20 new homeopathy clinics across India and abroad.
Agriculture minister Radha Mohan Singh has said that the government will not allow companies such as Monsanto to exploit farmers and it will continue to regulate the prices of seeds and pharmaceuticals. “Monsanto is a good company.
No comments:
Post a Comment